Journal of Vaccines & Vaccination

Convergence of global vaccines markets

15^th Annual Summit on Vaccines and Immunization

February 20-21, 2017 Berlin, Germany

Sourabh Sobti

Clinton Health Access Initiative, USA

Posters & Accepted Abstracts: J Vaccines Vaccin

Abstract:

Historically there has been a delay of ~10-20 years in vaccines getting introduced in developing countries after they were launched in developed markets. Now with support from global donors and Gavi, the lag between vaccine introductions in developed versus developing has shortened to ~3 years and is set to reduce further. Thus, we find all leading vaccines such as PCV, HPV, Rotavirus and IPV now available in expanded program of immunization (EPI) of various low and middle income countries. Few suppliers are also now flipping the model and following bottom of pyramid approach where developed country suppliers are prioritizing product approvals and launch in developing countries earlier than developed countries. The top 10 vaccines by revenues globally, are also topselling in private markets in low and middle income countries (LMICs), indicating that as prosperity and GDP increases in LMICs. We will see an increased demand for these products in those countries and hence no longer can suppliers can view the developed markets and developing countries from different lenses; but more as a common markets.

Biography :

Email: sourabh.sobti@gmail.com